Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #7016
Reference
MSAN(2020)73
Name
Fluticasone propionate (Flixotide®) 0.5mg/2ml and 2mg/2ml Nebules
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
SUPPLIES
Description
1. Flixotide® 0.5mg/2ml and 2mg/2ml nebules are out of stock from late June and August 2020, respectively.
2. Re-supplies of both strengths are expected from Mid-December 2020.
3. Unlicensed imports of fluticasone 0.5mg/2ml and 2mg/2ml nebules have been sourced.
4. UKMi have provided clinical advice on switching to alternative inhaled or nebulised corticosteroids.
2. Re-supplies of both strengths are expected from Mid-December 2020.
3. Unlicensed imports of fluticasone 0.5mg/2ml and 2mg/2ml nebules have been sourced.
4. UKMi have provided clinical advice on switching to alternative inhaled or nebulised corticosteroids.
Contact Name
Contact Email
Contact Address
Created
2020-07-27 00:00:00
Click to go back to homepage